Company: APXIF
Filing Date: 2025-06-13
Form Type: F-4/A
Source: 0001213900-25-054324
Chunk: 472

Company: APx Acquisition Corp. I
Filing Date: 2025-06-13
Form: F-4/A
Chunk 472
---
 Solutions Corp. non -executivedirector since March 2019. She also serves as a non -executivedirector of Moolec Science SA, chair of the audit and compensation committee. She currently advises Gameto, a women -ledbiotech company developing treatment solutions to improve women’s reproductive health. She served as the COO of Jazzya Investments, member of the investment committee of MBV Fund and CFO of Overture Life a biotech company focused on automating procedures for embryology. Previously, Ms. Zang held C -levelpositions in several industries, including mining, retail and real estate. In late 2015, Ms. Zang joined President Macri’s administration in Argentina, initially as Undersecretary for the Chief of Staff and then as Secretary (General Coordinator of the G20). Ms. Zang is a sought -afterlecturer on business and women’s leadership issues, and she is active in mentoring programs for students and women entrepreneurs Ms. Zang received a master’s degree in finance from the Universidad del CEMA and a bachelor’s degree in Business Administration from the Universidad Torcuato Di Tella. Federico Trucco.Please see “ Management of the Company Prior to the Business Combination — Executive Officers.” Sandra Sánchez -Oldenhage .Upon the Closing of the Business Combination, Ms. Oldenhage is expected to serve as non -executivedirector of the Company. Sandra Sánchez -Oldenhageis a seasoned executive with 37 years of leadership in the life sciences sector, specializing in strategic growth and transformation across Latin America. She has held senior roles at global pharmaceutical leaders including Pfizer, Merck, and Novartis, and led the successful market entry and expansion of Amgen and Biogen in Mexico. As founder and CEO of PharmAdvice, she advises companies on commercial strategy, regulatory affairs, and market access. Recognized among Mexico’s top businesswomen by CNN Expansión and Forbes, Sandra has served on numerous boards including PROCAPS Group (NASDAQ: PROC), Centro Médico ABC, and CANIFARMA. She holds an MBA from ITESM, and executive education credentials from Harvard, Cambridge, and Washington University in St. Louis. Directors and Senior Management Compensation Following the Closing of the Business Combination, we expect our executive compensation program to reflect our compensation policies and philosophies, as they may be modified and updated from time to time. We expect that decisions with respect to the compensation of our executive officers and senior management team, including our named